Data Gathering for A10900 (NCT07149740)

🧪 Interventions in This Study

• OCT (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (4 Sites)

• Ketchum Health — Anaheim, California
• Eye Disease Consultants, LLC — West Hartford, Connecticut
• Eye Care and Laser Surgery of Newton Wellselley — Wellesley Hills, Massachusetts
• Charles Retina Institute — Germantown, Tennessee

📞 Contact the Study Coordinator

Phone: (714) 423-9498

Email: sparker@ketchum.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Retinal Disease

• Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections — San Antonio, Texas
• COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease — Madison, Wisconsin
• Stem Cell Ophthalmology Treatment Study II — Westport, Connecticut
• Optimize Pediatric OCT Imaging — Durham, North Carolina
• Cell Collection to Study Eye Diseases — Bethesda, Maryland

Explore by condition: All Retinal Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.